SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-14-047265
Filing Date
2014-07-15
Accepted
2014-07-15 19:08:30
Documents
2
Period of Report
2014-07-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1567
2 EX-24 DOCUMENT attachment1.htm EX-24 3850
  Complete submission text file 0001209191-14-047265.txt   7081
Mailing Address 699 BOYLSTON ST 11TH FLOOR BOSTON MA 02116
Business Address 699 BOYLSTON ST 11TH FLOOR BOSTON MA 02116 617-600-4164
EPIRUS Biopharmaceuticals, Inc. (Issuer) CIK: 0001135906 (see all company filings)

IRS No.: 043514457 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EPIRUS BIOPHARMACEUTICALS, INC. 399 BOYLSTON ST., 11TH FL BOSTON MA 02116
Business Address
Seth Kim (Reporting) CIK: 0001613485 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51171 | Film No.: 14976785